Clinical Trial Update: A Study of AL102 in Patients With Progressing Desmoid Tumors [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for AL102 in progressing desmoid tumors, currently active/not recruiting across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Fibromatosis
• Desmoid Tumor

Drugs mentioned

• AL102

Snippet

Sponsor: Immunome, Inc. | Conditions: Desmoid, Desmoid Tumor | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING